Free Section (30%): Market Overview & Strategic Context
China’s traditional Chinese medicine (TCM) sector is undergoing a major transformation, integrating millennia-old medical theory with cutting-edge technologies such as AI, digital manufacturing, and blockchain-based supply chains.
The government’s 15th Five-Year Plan (2026–2030) and related industrial policies aim to build high-standard herbal raw-material bases, national innovation centers, and smart manufacturing plants, signaling strong domestic support and market growth.
With TCM accounting for over a quarter of China’s pharmaceutical industry and generating more than 1 trillion yuan in annual revenue, overseas investors have a growing opportunity to tap a sector transitioning from volume-driven expansion to innovation-led growth.
Paid Section (70%): Operational Insights, Innovation, and Investment Opportunities
this is standard content, view need get membership